Perform search
Products
Menu

June 4, 2008

Extended Infant Antiretroviral Prophylaxis Reduces HIV Risk During Breastfeeding

Filed under: Uncategorized — @ 11:00 pm
In many resource-poor countries, infants born to mothers with HIV receive a single dose of nevirapine (NVP) and a one-week dose of zidovudine (ZDV) to prevent transmission of HIV from the mother to her newborn. The results of a randomized trial led by researchers at the Johns Hopkins Bloomberg School of Public Health and the University of Malawi College of Medicine found that extending the routine antiretroviral regimen can significantly reduce the risk of mother-to-child HIV transmission. The study is available in the June 4 online edition of New England Journal of Medicine and will appear in the June 10 print edition. The Malawi trial, known as PEPI (post-exposure prophylaxis of infants), followed 3,016 infants born to HIV-positive mothers. The infants and mothers were followed for 2 years. All infants received the standard care of a single dose of NVP and a one-week dose of ZDV to prevent HIV infection. One group received an additional 14-week prophylaxis with NVP, while another received 14-week regimens of both NVP and ZDV. Throughout the trial, the children who received the extended prophylactic regimens had consistently lower rates of HIV infection compared to children who received the standard care. At 9 months, 5.2 percent of infants receiving extended NVP, and 6.4 percent of infants receiving extended NVP and ZDV contracted HIV, compared to 10.6 percent of infants receiving the standard of care regimen. The frequency at which the mothers breastfed their children was similar between all three treatment groups. “We know that breastfeeding in the first 6 months of life is extremely important for the child’s health and survival, especially in resource poor countries. However, women with HIV face a difficult choice because they are also putting the child at risk for HIV,” said Taha E. Taha, MD, PhD, senior author of the study and professor in the Bloomberg School’s Department of Epidemiology. “Our findings clearly show that extended drug regimens can significantly reduce the risk of HIV transmission from breastfeeding.” According to the researchers, the proportion of infants experiencing adverse events from the medications was similar in all groups. However, infants who received extended NVP and ZDV more commonly experienced neutropenia, which is a decrease in certain types of white blood cells. The study was supported by the Centers for Disease Control and Prevention and the National Institutes of Child Health and Human Development, National Institutes of Health. “Extended Infant Antiretroviral Prophylaxis Reduces Breast Milk HIV-1 Transmission” was written by Newton I. Kumwenda, PhD; Donald R. Hoover, PhD; Lynne M. Mofenson, MD; Michael C. Thigpen, MD; George Kafulafula, MBBS, FCOG; Qing Li, MSc; Linda Mipando, MSc; Kondwani Nkanaunena, MSc; Tsedal Mebranhtu, ScM; Marc Bulterys, MD, PhD; Mary Glenn Fowler, MD, MPH; and Taha E. Taha, MD, PhD.

Programs Can Reduce Risky Sex Among HIV-positive Minority Men

Filed under: Uncategorized — @ 10:10 pm
Research has shown that HIV-positive African American and Hispanic men who were sexually abused as children are particularly vulnerable to engaging in high-risk sex and experiencing depressive symptoms. Yet few HIV intervention programs exist to help them. Now, a new study by UCLA's Center for Culture, Trauma and Mental Health Disparities has found that interventions that address the life experiences of these men — including their early sexual experiences — in addition to risk and general health issues can contribute significantly toward preventing high-risk behavior and reducing depression rates. The success is largely due to the social support found within these programs, researchers say. And while brief interventions may be effective in the short term, periodic "boosters," or additional sessions, may be needed to reinforce positive changes over time, according to the study authors. The study is currently available in the online version of the peer-reviewed Archives of Sexual Behavior at http://www.springerlink.com/content/7j27370841074318/fulltext.html. "Usually, what you find after people complete interventions is that their behaviors have improved," said Dr. John Williams, assistant professor of psychiatry and biobehavioral sciences at the Semel Institute for Neuroscience and Human Behavior at UCLA and the study's lead researcher. "But as time goes on, they tend to revert to their old behaviors. Changing one's behavior is very difficult. We see that with all sorts of behaviors, like smoking and dieting. But with sex, it's even more difficult." The study findings are from the UCLA Men's Health Study, a three-year project undertaken between 2003 and 2006 to develop and test HIV risk-reduction interventions. For this study, researchers recruited 137 HIV-positive gay and bisexual African American and Hispanic men who had a history of childhood sexual abuse. Participants were generally middle-aged, poor, had little formal education and were predominately single, lacking long-term partners and family support. Participants were assigned to one of two intervention programs the researchers sought to compare: one, known as the Sexual Health Intervention for Men (S-HIM), was aimed at lowering high-risk behaviors, such as unprotected sex and multiple sex partners; the other, the Standard Health Promotion (SHP), focused on health issues unrelated to sexual behavior, such as diet, exercise, rest and medication adherence. Both programs consisted of six weekly, two-hour sessions with groups of five to seven men. The men were split into African American or Hispanic groups, with each group led by an ethnically matched mentor. Follow-ups were conducted immediately after the sixth session, as well as three and six months later. Researchers found that men from both intervention groups reduced risky behaviors and their number of sexual partners and also experienced a decrease in depressive symptoms. The S-HIM group participants, however, demonstrated a significantly greater decrease in risky behavior from the beginning of the study to the immediate post-program survey. And while there were no significant differences in decreased depression between the two groups, men from the whole sample reported a significant decrease in depressive symptoms by the six-month follow-up. The social support the participants found in these groups, where they were able to share their experiences — including those concerning childhood sexual abuse — likely contributed to this outcome, Williams said. "Boosters" may be necessary so that participants can revisit and practice skills that they have learned, he said. For instance, participants can practice applying condoms to a penis model so they become familiar with the common errors in using condoms and feel more confident in using one correctly. "Interventions that address sexual abuse among ethnic minority men need to be developed, as they may have never previously disclosed their abuse histories or explored the impact of this experience in their current lives, especially as it relates to sexual decision-making," the authors said. "Understanding the meaning of CSA (childhood sexual abuse) in cultures where being sexually abused would preclude positive images of strength and prowess need to be considered when working with ethnically and racially diverse men." In addition to Williams, authors included Gail E. Wyatt, Hema Codathi Ramamurthi and Xiaomin Li of the department of psychiatry and biobehavioral sciences at the Semel Institute for Neuroscience and Human Behavior at UCLA; Honghu Liu of the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA; and Inna Rivkin of the department of psychology at the University of Alaska, Fairbanks. The University of California's California HIV/AIDS Research Program funded this study.
Drug store